September 16, 2014
Why is a payday loan right for you Payday loan 50 up to
Payday loans uk

HCV Behind Bars: Part I

Posted on September 9, 2014 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Treatment Behind Bars Part I: Who pays for direct-acting antiretrovirals in prisons? by Larry Buhl The new class of direct-acting antiretrovirals (DAAs) that have revolutionized treatment of hep C have greatly boosted the chances of recovery. The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America [...]

Hep Advocacy Goes Global

Posted on August 4, 2014 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] All Around the World The war on hepatitis goes global by Larry Buhl The hepatitis crisis has been a global one for some time, but 2014 marks a watershed as NGOs, governments, activists, and pharmaceutical companies have set down important markers in how to address the pandemic. And they’re also beginning to [...]

Hep A Prevention

Posted on June 24, 2014 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Food for Thought Hepatitis A prevention efforts spark controversy by Larry Buhl The hepatitis C virus gets a lot of attention, and rightly so, because it can and does kill. But several high profile outbreak scares from infected restaurant workers has put the less deadly hepatitis A virus (HAV) on the map [...]

HCV & Underreporting

Posted on May 13, 2014 by in Hep Talk, LifeGuide

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C virus (HCV) in the U.S. shows that, with a “silent epidemic,” it’s hard to get accurate numbers. A disease that often has no symptoms, and that hits populations [...]

Race to the Hep C Cure

Posted on March 24, 2014 by in Hep Talk, LifeGuide

Race to the Cure Who are the biggest players now in eradicating hepatitis C? by Larry Buhl Beyond the implementation of the Affordable Care Act, one of the biggest healthcare stories of 2013 was the emerging race of pharmaceutical companies to bring new drugs to the market to cure hepatitis C. The advent of direct-acting [...]

Coffee & HCV

Posted on March 6, 2014 by in Hep Talk, LifeGuide

Coffee Talk Two studies shed light on HCV prevention & treatment by Larry Buhl A study on the long-term infectiousness of the hepatitis C virus (HCV) has implications for healthcare workers, IV drug users, and tattoo artists, while another study shows the benefits of coffee and tea on liver inflammation in chronic hepatitis C patients. [...]

HCV Serosorting

Posted on January 24, 2014 by in Hep Talk, LifeGuide

Testing, Testing Serosorting is common for IV drug users who know their HCV status by Larry Buhl A new study shows IV drug users who know they carry the hepatitis C virus are likely to consider their serostatus when deciding whether and with whom to share injection equipment. The results, published in the December 15, [...]

Direct-Acting Antivirals & HCV

Posted on December 31, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl Two Agents New direct-acting antivirals cross a major hurdle                       The Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) in October gave unanimous recommendations for approval of two next-generation direct-acting antivirals (DAAs) for hepatitis C, Janssen’s [...]

African Americans & HCV

Posted on December 4, 2013 by in Hep Talk, LifeGuide

“Race” Matters Researchers study disparities when it comes to African Americans & HCV by Larry Buhl               A growing number of clinicians and researchers want the African-American community to understand that not only is there a racial disparity in care and treatment, there are differences in the way HCV [...]

Hep C & Adult Films

Posted on October 30, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl Hep X Does the porn industry have a hepatitis problem? Actors who work for legitimate adult entertainment producers, who are mostly based in Los Angeles, now have to submit to monthly tests for hepatitis B and C as well as for Trichomoniasis vaginalis, a sexually transmitted infection of the urogenital [...]